Novel Lignan and Stilbenoid Mixture Shows Anticarcinogenic Efficacy in Preclinical PC-3M-luc2 Prostate Cancer Model
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Novel Lignan and Stilbenoid Mixture Shows Anticarcinogenic Efficacy in Preclinical PC-3M-luc2 Prostate Cancer Model
Authors
Keywords
Apoptosis, Phenols, Metabolites, Urine, Prostate cancer, Cell proliferation, Cancer treatment, Bioluminescence
Journal
PLoS One
Volume 9, Issue 4, Pages e93764
Publisher
Public Library of Science (PLoS)
Online
2014-04-04
DOI
10.1371/journal.pone.0093764
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The antitumor lignan Nortrachelogenin sensitizes prostate cancer cells to TRAIL-induced cell death by inhibition of the Akt pathway and growth factor signaling
- (2013) Emilia Peuhu et al. BIOCHEMICAL PHARMACOLOGY
- Suppression of Src/ERK and GSK-3/β-catenin signaling by pinosylvin inhibits the growth of human colorectal cancer cells
- (2013) Eun-Jung Park et al. FOOD AND CHEMICAL TOXICOLOGY
- Dietary Resveratrol Prevents Development of High-Grade Prostatic Intraepithelial Neoplastic Lesions: Involvement of SIRT1/S6K Axis
- (2012) G. Li et al. Cancer Prevention Research
- Improved Statistical Modeling of Tumor Growth and Treatment Effect in Preclinical Animal Studies with Highly Heterogeneous Responses In Vivo
- (2012) T. D. Laajala et al. CLINICAL CANCER RESEARCH
- Resveratrol role in cardiovascular and metabolic health and potential mechanisms of action
- (2012) Qiang Xu et al. NUTRITION RESEARCH
- Polyphenol-rich sweet potato greens extract inhibits proliferation and induces apoptosis in prostate cancer cells in vitro and in vivo
- (2011) Prasanthi Karna et al. CARCINOGENESIS
- Chemical characterization of polymerized products formed in the reactions of matairesinol and pinoresinol with the stable radical 2,2-diphenyl-1-picrylhydrazyl
- (2011) Annika I. Smeds et al. HOLZFORSCHUNG
- Piceatannol inhibits migration and invasion of prostate cancer cells: possible mediation by decreased interleukin-6 signaling
- (2011) Gyoo Taik Kwon et al. JOURNAL OF NUTRITIONAL BIOCHEMISTRY
- Resveratrol in human cancer chemoprevention - Choosing the ‘right’ dose
- (2011) Edwina Scott et al. MOLECULAR NUTRITION & FOOD RESEARCH
- What Is New for an Old Molecule? Systematic Review and Recommendations on the Use of Resveratrol
- (2011) Ole Vang et al. PLoS One
- Death Receptor Agonists as a Targeted Therapy for Cancer
- (2010) J. Wiezorek et al. CLINICAL CANCER RESEARCH
- Differential effects of resveratrol and its naturally occurring methylether analogs on cell cycle and apoptosis in human androgen-responsive LNCaP cancer cells
- (2010) Thomas T. Y. Wang et al. MOLECULAR NUTRITION & FOOD RESEARCH
- Diet and prostate cancer: mechanisms of action and implications for chemoprevention
- (2010) Vasundara Venkateswaran et al. Nature Reviews Urology
- New insights into apoptosis signaling by Apo2L/TRAIL
- (2010) F Gonzalvez et al. ONCOGENE
- Resveratrol Enhances Antitumor Activity of TRAIL in Prostate Cancer Xenografts through Activation of FOXO Transcription Factor
- (2010) Suthakar Ganapathy et al. PLoS One
- Nutraceuticals and prostate cancer prevention: a current review
- (2009) Greg Trottier et al. Nature Reviews Urology
- Inhibition of Akt signaling by the lignan matairesinol sensitizes prostate cancer cells to TRAIL-induced apoptosis
- (2009) E Peuhu et al. ONCOGENE
- Differential effects of resveratrol on androgen-responsive LNCaP human prostate cancer cells in vitro and in vivo
- (2008) T. T.Y. Wang et al. CARCINOGENESIS
- Enterolactone restricts the proliferation of the LNCaP human prostate cancer cell linein vitro
- (2008) Mark J. McCann et al. MOLECULAR NUTRITION & FOOD RESEARCH
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started